Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Neuroscience (ANRO) Prepaid Assets (2023 - 2026)

Alto Neuroscience has reported Prepaid Assets over the past 4 years, most recently at $5.4 million for Q1 2026.

  • Quarterly results put Prepaid Assets at $5.4 million for Q1 2026, up 93.72% from a year ago — trailing twelve months through Mar 2026 was $5.4 million (up 93.72% YoY), and the annual figure for FY2025 was $1.2 million, up 11.37%.
  • Prepaid Assets reached $5.4 million in Q1 2026 per ANRO's latest filing, up from $1.2 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $5.4 million in Q1 2026 and bottomed at $277000.0 in Q3 2024.
  • Median Prepaid Assets over the past 4 years was $2.3 million (2024), compared with a mean of $2.2 million.
  • The largest annual shift saw Prepaid Assets crashed 61.03% in 2024 before it skyrocketed 489.17% in 2025.
  • Over 4 years, Prepaid Assets stood at $2.8 million in 2023, then plummeted by 61.03% to $1.1 million in 2024, then grew by 11.37% to $1.2 million in 2025, then soared by 334.68% to $5.4 million in 2026.
  • Business Quant data shows Prepaid Assets for ANRO at $5.4 million in Q1 2026, $1.2 million in Q4 2025, and $1.6 million in Q3 2025.